Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Stromal Tumors | 6 | 2022 | 17 | 3.600 |
Why?
|
| Gastrointestinal Neoplasms | 4 | 2022 | 26 | 2.690 |
Why?
|
| Leiomyosarcoma | 2 | 2022 | 11 | 1.760 |
Why?
|
| Proto-Oncogene Proteins c-kit | 4 | 2022 | 33 | 1.190 |
Why?
|
| Carcinogenesis | 3 | 2022 | 109 | 1.130 |
Why?
|
| Transcription Factors | 4 | 2022 | 1439 | 1.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 110 | 0.980 |
Why?
|
| Histone Acetyltransferases | 1 | 2022 | 66 | 0.920 |
Why?
|
| Uterus | 1 | 2020 | 40 | 0.810 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 238 | 0.750 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2009 | 59 | 0.740 |
Why?
|
| Transcriptome | 2 | 2022 | 280 | 0.730 |
Why?
|
| Amyloid beta-Peptides | 4 | 2007 | 141 | 0.710 |
Why?
|
| Proteomics | 2 | 2009 | 199 | 0.670 |
Why?
|
| Endometrial Stromal Tumors | 1 | 2017 | 1 | 0.670 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 428 | 0.660 |
Why?
|
| 14-3-3 Proteins | 1 | 2017 | 18 | 0.660 |
Why?
|
| Endometrial Neoplasms | 1 | 2017 | 48 | 0.630 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 694 | 0.630 |
Why?
|
| Proteins | 2 | 2022 | 713 | 0.620 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2007 | 127 | 0.580 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 275 | 0.520 |
Why?
|
| Inflammation | 1 | 2020 | 942 | 0.520 |
Why?
|
| Alzheimer Disease | 2 | 2007 | 377 | 0.480 |
Why?
|
| Neprilysin | 2 | 2007 | 9 | 0.420 |
Why?
|
| Plaque, Amyloid | 2 | 2007 | 27 | 0.420 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2022 | 42 | 0.410 |
Why?
|
| Mice | 10 | 2022 | 9050 | 0.380 |
Why?
|
| Gene Expression | 3 | 2022 | 774 | 0.380 |
Why?
|
| Captopril | 2 | 2007 | 9 | 0.380 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2007 | 36 | 0.370 |
Why?
|
| Humans | 19 | 2022 | 48582 | 0.360 |
Why?
|
| HEK293 Cells | 3 | 2019 | 530 | 0.350 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 476 | 0.310 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 1271 | 0.310 |
Why?
|
| Animals | 12 | 2022 | 17853 | 0.300 |
Why?
|
| Cell Proliferation | 2 | 2019 | 888 | 0.260 |
Why?
|
| Cell Line | 4 | 2009 | 1975 | 0.250 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2022 | 7 | 0.240 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2022 | 12 | 0.240 |
Why?
|
| Heterografts | 1 | 2022 | 59 | 0.230 |
Why?
|
| Germinal Center | 1 | 2022 | 33 | 0.230 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 321 | 0.230 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 26 | 0.220 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 107 | 0.220 |
Why?
|
| Graft vs Host Disease | 1 | 2022 | 83 | 0.220 |
Why?
|
| Benzodiazepines | 1 | 2021 | 79 | 0.220 |
Why?
|
| Receptors, CCR | 1 | 2021 | 2 | 0.220 |
Why?
|
| Protein Domains | 2 | 2019 | 128 | 0.220 |
Why?
|
| Genetic Therapy | 1 | 2007 | 571 | 0.220 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 142 | 0.220 |
Why?
|
| Immunoconjugates | 1 | 2021 | 43 | 0.210 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 450 | 0.200 |
Why?
|
| Succinate Dehydrogenase | 1 | 2019 | 11 | 0.200 |
Why?
|
| Substrate Specificity | 3 | 2009 | 310 | 0.190 |
Why?
|
| Chromosome Aberrations | 1 | 2019 | 56 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 174 | 0.190 |
Why?
|
| Oncogenes | 1 | 2019 | 64 | 0.190 |
Why?
|
| Azepines | 1 | 2019 | 19 | 0.190 |
Why?
|
| Sarcoma, Synovial | 1 | 2018 | 5 | 0.190 |
Why?
|
| Imatinib Mesylate | 1 | 2019 | 37 | 0.190 |
Why?
|
| Triazoles | 1 | 2019 | 61 | 0.180 |
Why?
|
| Survival Rate | 1 | 2021 | 666 | 0.180 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2019 | 47 | 0.180 |
Why?
|
| Disease Progression | 2 | 2018 | 704 | 0.180 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 13 | 0.180 |
Why?
|
| Mice, Nude | 1 | 2019 | 227 | 0.180 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 165 | 0.180 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 180 | 0.170 |
Why?
|
| Proteolysis | 1 | 2018 | 116 | 0.170 |
Why?
|
| Immunoblotting | 2 | 2008 | 186 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 138 | 0.170 |
Why?
|
| Mutation | 3 | 2019 | 2254 | 0.170 |
Why?
|
| Taxoids | 1 | 2017 | 25 | 0.160 |
Why?
|
| Chromatin | 1 | 2022 | 557 | 0.160 |
Why?
|
| Deoxycytidine | 1 | 2017 | 26 | 0.160 |
Why?
|
| Cricetinae | 3 | 2007 | 389 | 0.160 |
Why?
|
| Gene Rearrangement | 1 | 2017 | 38 | 0.160 |
Why?
|
| Neoplasm Grading | 1 | 2017 | 70 | 0.160 |
Why?
|
| Prognosis | 1 | 2021 | 1244 | 0.160 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 809 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 430 | 0.150 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 540 | 0.150 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 1921 | 0.150 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 1798 | 0.140 |
Why?
|
| Female | 4 | 2021 | 26134 | 0.140 |
Why?
|
| Mice, Transgenic | 3 | 2007 | 1125 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 820 | 0.140 |
Why?
|
| Cells, Cultured | 2 | 2008 | 2063 | 0.120 |
Why?
|
| Apoptosis | 1 | 2019 | 1025 | 0.120 |
Why?
|
| Neoplasms | 1 | 2021 | 985 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 2 | 2007 | 2901 | 0.100 |
Why?
|
| Amino Acid Sequence | 3 | 2009 | 1580 | 0.100 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2009 | 19 | 0.100 |
Why?
|
| Culture Media, Conditioned | 1 | 2009 | 48 | 0.100 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 1995 | 0.100 |
Why?
|
| CHO Cells | 2 | 2007 | 188 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2009 | 288 | 0.090 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2008 | 14 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 114 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 176 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2008 | 105 | 0.090 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2008 | 62 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2008 | 111 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2008 | 349 | 0.090 |
Why?
|
| Transplants | 1 | 2007 | 7 | 0.080 |
Why?
|
| Gliosis | 1 | 2007 | 16 | 0.080 |
Why?
|
| Cricetulus | 1 | 2007 | 97 | 0.080 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 82 | 0.080 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 20 | 0.080 |
Why?
|
| Triglycerides | 1 | 2008 | 242 | 0.080 |
Why?
|
| HeLa Cells | 1 | 2008 | 544 | 0.080 |
Why?
|
| Retrospective Studies | 1 | 2017 | 4404 | 0.080 |
Why?
|
| Brain Chemistry | 1 | 2007 | 78 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 135 | 0.070 |
Why?
|
| Insulysin | 1 | 2005 | 3 | 0.070 |
Why?
|
| Adult | 2 | 2021 | 13139 | 0.070 |
Why?
|
| Transfection | 1 | 2007 | 650 | 0.070 |
Why?
|
| Middle Aged | 2 | 2021 | 13417 | 0.070 |
Why?
|
| Catalysis | 1 | 2005 | 144 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2005 | 130 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2009 | 784 | 0.070 |
Why?
|
| Hyperkinesis | 1 | 2003 | 2 | 0.060 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2003 | 11 | 0.060 |
Why?
|
| Insecticides | 1 | 2003 | 27 | 0.060 |
Why?
|
| Binding Sites | 1 | 2005 | 859 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2007 | 680 | 0.060 |
Why?
|
| Haplorhini | 1 | 2021 | 14 | 0.050 |
Why?
|
| Japan | 1 | 2021 | 41 | 0.050 |
Why?
|
| Insulin | 1 | 2005 | 660 | 0.050 |
Why?
|
| Brain | 2 | 2005 | 1163 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2022 | 324 | 0.050 |
Why?
|
| Fibroblast Growth Factor 4 | 1 | 2019 | 7 | 0.050 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2019 | 8 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 99 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 546 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 391 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2022 | 669 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 450 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2019 | 257 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2018 | 1443 | 0.040 |
Why?
|
| Rats | 1 | 2021 | 1809 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 259 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 897 | 0.030 |
Why?
|
| Protein Binding | 1 | 2018 | 1534 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4214 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 3615 | 0.030 |
Why?
|
| Adolescent | 1 | 2021 | 5300 | 0.030 |
Why?
|
| United States | 1 | 2021 | 6100 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 10802 | 0.020 |
Why?
|
| RNA 3' Polyadenylation Signals | 1 | 2005 | 2 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2005 | 47 | 0.020 |
Why?
|
| Dimerization | 1 | 2005 | 146 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2005 | 133 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2005 | 175 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2005 | 164 | 0.020 |
Why?
|
| Cytosol | 1 | 2005 | 156 | 0.020 |
Why?
|
| Exons | 1 | 2005 | 187 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2003 | 27 | 0.020 |
Why?
|
| Acetylcholinesterase | 1 | 2003 | 12 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 2003 | 86 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2003 | 60 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 2003 | 27 | 0.020 |
Why?
|
| Kinetics | 1 | 2005 | 719 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2003 | 148 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2003 | 76 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2003 | 147 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 237 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 365 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 1317 | 0.010 |
Why?
|
| Male | 1 | 2021 | 23090 | 0.010 |
Why?
|
| Mitochondria | 1 | 2005 | 288 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 253 | 0.010 |
Why?
|
| Alleles | 1 | 2003 | 414 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 590 | 0.010 |
Why?
|
| Phenotype | 1 | 2003 | 1007 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 767 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 3188 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 1534 | 0.010 |
Why?
|